Comment on 'Renewed interest in the progesterone receptor in breast cancer'
Br J Cancer
.
2017 Jul 11;117(2):e1.
doi: 10.1038/bjc.2017.90.
Epub 2017 Apr 11.
Authors
Giovanni Simone
1
,
Sergio Diotaiuti
2
,
Maria Digennaro
3
,
Domenico Sambiasi
3
,
Simona De Summa
4
,
Stefania Tommasi
4
,
Rosanna Altieri
2
,
Annita Mangia
5
,
Caterina Dantona
6
,
Angelo Paradiso
3
Affiliations
1
Pathology Unit, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.
2
Senology Unit, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.
3
Experimental Medical Oncology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.
4
Molecular Genetics, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.
5
Functional Biomorphology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.
6
Department of General Surgery,Ospedale Civico di Lugano, Via Tesserete 46, 6900 Lugano, Switzerland.
PMID:
28399113
PMCID:
PMC5520524
DOI:
10.1038/bjc.2017.90
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers, Tumor
Breast Neoplasms*
Humans
Receptors, Progesterone*
Substances
Biomarkers, Tumor
Receptors, Progesterone